Tuesday, 9 April 2019

Urolithiasis Management Devices Market Significant Profits Estimated to be Generated by 2024: Grand View Research Inc.


San Francisco, 9 April 2019: The Report Urolithiasis Management Devices Market Analysis By Treatment Type (Extracorporeal Shock Wave Lithotripsy (Eswl), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Other Treatments (Watchful Waiting, Parathyroid Gland Surgery)), By End Use (Hospitals & Clinics, Ambulatory Surgical Centers), And Segment Forecasts To 2024

The global urolithiasis management devices market was valued at USD 1.27 billion in 2015 and is expected to be valued at USD 1.93 billion by 2024. The alarming growth in the incidence rate of urinary stones, over the years, is responsible for the advancements in the treatment options. European Association of Urology states that it is one of the most common lifestyle disorders with a 10% prevalence rate and requires a systematic treatment approach.

Urolithiasis means formation of stones in the urinary system, mainly including the kidney, ureters, and the bladder. It is a major healthcare concern in the high end countries such as the U.S., Canada, and Germany with a recurrence rate of 50% in most of the cases. Urolithiasis can be managed with the help of lifestyle changes, controlled diet, or basic medication. However, various treatment approaches need to be adopted for the removal of large stones that cause severe pain. Depending upon the stone size, location in the body, and anatomical variations in the urogenital tract, invasive or noninvasive stone removal procedures are available. For instance, smaller stones can be tackled with external shock waves (extracorporeal shock wave lithotripsy), while larger stones can be removed through surgeries (intracorporeal lithotripsy or percutaneous nephrolithotomy).
Smaller stones generally do not require surgical interventions and can be cured with the help of medication and a healthy diet. However, larger stones necessitate different approaches for their elimination. Extracorporeal lithotripsy is one of the common treatments employed for stone elimination and held a majority market share in the year 2015. Intracorporeal lithotripsy treatments spot and reduce the stones to smaller pieces with the help of endoscopy. For the disintegration of stones, ultrasound or laser techniques are used to enable the passage of smaller fragments through the urinary system. Owing to the effective stone-free rate offered by intracorporeal lithotripsy, it is likely to be preferred as a treatment option during the forecast period.
Furthermore, percutaneous nephrolithotomy is a surgical approach deployed to eliminate larger stones where extracorporeal or intracorporeal lithotripsies prove to be ineffective and typically require a week’s hospitalization.
Ambulatory surgical centers are gaining popularity over traditional hospital and clinic settings due to the time and cost saving benefits. As a result, this end-use segment is expected to record a lucrative growth rate during the forecast period. Introduction of novel surgical technologies, such as endoscopy and micro accessories including guidewires, scalpels, and baskets, to effectively expel stones from the urinary system in a short time has enhanced the overall acceptability of minimally invasive surgeries.
Access Research Report of Urolithiasis Management Devices Market @ http://www.grandviewresearch.com/industry-analysis/urolithiasis-management-devices-market

Further Key Findings from the Study Suggest:
·       Urinary stones are highly prevalent worldwide with a 15% global target population and the recurrence rate of 50%. Men are more susceptible to developing renal stones than women.
·       Adoption and acceptance of intracorporeal lithotripsy contributed to more than 95% stone-free rate, which will render it the most preferred alternative over extracorporeal and subcutaneous treatments. On the other hand, ambulatory surgical centers will grow at a higher rate due to the associated benefits of lower cost and shorter perioperative time.
·       The upward trend in the adoption of sedentary lifestyle coupled with increased consumption of unhealthy food in the developed countries is responsible for the rising incidence of kidney stones. Ambulatory surgical service providers are expected to experience a surge in the treatment demand as a result of the unhealthy lifestyle changes, especially in the developed countries.
Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the urolithiasis management devices market by treatment type, end use, and region:
Treatment Type Outlook (Market revenue in USD Million, 2013 - 2024)
·         Extracorporeal Shock Wave Lithotripsy (ESWL)
·         Intracorporeal Lithotripsy
·         Percutaneous Nephrolithotomy
·         Other Treatments
End Use Outlook (Market Revenue in USD Million, 2013 - 2024)
·         Hospitals & Clinics
·         Ambulatory Surgical Centers
Regional Outlook (Market Revenue in USD Million, 2013 - 2024)
·         North America
·         Europe
·         Asia Pacific
·         Latin America
·         Middle East and Africa
Access Press Release of Urolithiasis Management Devices Market@ https://www.grandviewresearch.com/press-release/global-urolithiasis-management-devices-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com

Monday, 8 April 2019

Mammography Market is Expected To Develop at a CAGR of 10.5% from 2016 to 2025: Grand View Research Inc.


San Francisco, 8 April 2019: The Report Mammography Market Analysis by Product, (Film Screen Systems, Digital Systems, Analog Systems, Biopsy Systems, 3D Systems), By Technology, (Breast Tomosynthesis, CAD, Digital), By Application, And Segment Forecasts, 2018 - 2025

The global mammography market is expected to reach a value of USD 3.8 billion by 2025, according to a new report by Grand View Research, Inc. The market growth can be attributed to the rising initiatives by various governments and NGOs to raise awareness about early diagnosis of microcalcifications in breast tissue. Some significant organizations such as the National Breast Cancer Foundation, CDC, and Breast Cancer Organization are promoting the early diagnosis of mammary gland calcification, which is one of the crucial factors expected to drive the demand over the forecast period.

Based on a report published by the National Cancer Institute in 2015, it was stated that the proportion of women aged 45 to 65 years had increased to 81.1% in breast cancer screening. Major mammography manufacturers are introducing new products and increasing the number of approved products, which is further expected to impel the demand in the coming years.
In January 2016, FDA approved a new manual for digital mammography quality control by the American College of Radiology. The growing number of awareness campaigns to promote womens’ health services is also anticipated to propel growth.
Some of the key industry players are Fujifilm; Hologic; Philips Healthcare; Siemens Healthineers; Toshiba Medical Systems Corporation; GE Healthcare; Metaltronica; PLANMED OY; Mindray Medical International Limited; and IMS srl.
Access Research Report of Mammography Market @ http://www.grandviewresearch.com/industry-analysis/mammography-market

Further Key Findings From the Study Suggest:
·       Digital systems dominated the product segment in 2015 owing to the wide availability of digital breast screening devices and presence of favorable reimbursements for such devices
·       Digital mammography dominated the application segment in 2015 due to growing awareness regarding digital technology and increasing adoption of such technology for better diagnosis
·       In 2015, North America dominated due to the increasing adoption of technologically advanced screening devices and up surging number of approvals of 3D systems
·       Asia Pacific and Latin America are the two fastest growing regional segments, because of the higher mammary gland cancer prevalence and growing number of government campaigns to improve screening results
Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the mammography market by product, technology, and region: 
Product Outlook (Market Revenue in USD Million, 2013 - 2025)
·         Film Screen Systems
·         Digital Systems
·         Analog Systems
·         Biopsy Systems
·         3D Systems
Technology Outlook (Market Revenue in USD Million, 2013 - 2025)
·         Breast Tomosynthesis
·         CAD
·         Digital
Regional Outlook (Market Revenue in USD Million, 2013 - 2025)
·         North America
·         Europe
·         Asia Pacific
·         Latin America
·         Middle East and Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com

Well Cementing Services Market is Thriving USD 11.08 Billion Revenue by 2024: Grand View Research Inc.

San Francisco, 8 April 2019: The Report Well Cementing Services Market Analysis By Service (Primary Well Cementing, Remedial Well Cementing), By Application (Onshore, Offshore) And Segment Forecast To 2024

The global well cementing services market is expected to reach USD 11.08 billion by 2024, according to a new report by Grand View Research, Inc. Rising drilling activities to recover unconventional hydrocarbons such as shale and tight gas coupled with rehabilitation activities in existing oil & gas fields is expected to remain a key driving factor for the global market.

A large number of unexplored reserves particularly in Brazil, Russia, and China, coupled with technological advancements in well cementing equipment and services provided by oil service providers is projected to have a positive impact on the market growth in near future.
Stringent environmental regulations coupled with low crude oil prices are expected to hindermarket growth over the next eight years. Low crude oil prices are anticipated to support stronger economic growth, but it may hamper growth among energy producing states.
Primary cementing was the leading service segment and accounted for over 75% of total market revenue in 2015. It is estimated to remain the largest segment over the next eight years owing to rising E&P to exploit unconventional hydrocarbon reserves.Remedial cementing is anticipated to emerge as the fastest growing well cementing service market over the forecast period owing to increasing rehabilitation of oil & gas wells in both onshore and offshore activities.
Access Research Report of Well Cementing Services Market @ http://www.grandviewresearch.com/industry-analysis/well-cementing-services-market

Further key findings from the report suggest:
·       Onshore application dominated the global well cementing service demand and accounted for over 80% of total revenue in 2015. The rising onshore well operations, particularly in the U.S., Saudi Arabia, Russia, and China,may be attributed to the high growth in this particular segment.
·       North America emerged as the leading well cementing services consumer and accounted for 41.4% of the total revenue in 2015 owing to huge oil & natural gas production coupled with oilfield development especially in shale &tight oil reserves in the U.S. and Canada.
·       Asia Pacific well cementing services marketis anticipated to grow at a CAGR of 7.0% from 2016 to 2024.The high growth may be attributed to favorable government policies such as FDI and tax redemption in countries such as India, which is anticipated to promote E&P in the region.
·       The global industry is dominated by various integrated players present across the value chain. Key companies operating in the well cementing service market includeSchlumberger Ltd., Baker Hughes Inc., Halliburton, Weatherford & Gulf Energy Llc., and Calfrac Well Services Ltd.
Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/conventional-energy
Grand View Research has segmented the well cementing services market on the basis of service, application,and region:
Global Well Cementing Service Outlook (Revenue, USD Million, 2014 - 2024)
·         Primary
·         Remedial
·         Others
Global Well Cementing Application Outlook (Revenue, USD Million, 2014 - 2024)
·         Onshore
·         Offshore
Global Well Cementing Regional Outlook (Revenue, USD Million, 2014 - 2024)
·         North America
·         Europe
·         Asia Pacific
·         Middle East & Africa
·         Central & South America
Access Press Release of Well Cementing Services Market@ https://www.grandviewresearch.com/press-release/global-well-cementing-services-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com

Lung Cancer Diagnostics Market Size Is Predicted To Reach A Valuation Of USD 3,644.6 Million By 2024: Grand View Research Inc.


San Francisco, 8 April 2019: The Report Lung Cancer Diagnostics Market Analysis By Type (Small Cell Lung Cancer, Non-small Cell Lung Cancer), By Test (Imaging Test, Biopsy, Sputum Cytology, Molecular Testing), And Segment Forecasts To 2024

The global lung cancer diagnostics market is expected to reach USD 3,644.6 million by 2024, according to a new report by Grand View Research Inc. The development of lung cancer-specific biomarkers is one of the primary factors for the growth of the lung cancer diagnostics market over the forecast period. These diagnostic tools facilitate the personalized treatment approach of lung malignancies. 

Various biomarkers are present in the research pipeline. For instance, in November 2015, Epigenomics AG announced the launch of a new blood-based test using DNA methylation biomarkers, the development of which is underway. The initial results of this test revealed a promising outcome in the early diagnosis of lung cancer. 
Furthermore, various awareness programs focusing on lung cancer and its associated symptoms are initiated in an attempt to elevate the screening and diagnosis rates inindividuals at a high risk of developing lung malignancies. For instance, November is considered as a lung cancer awareness month across the UK, which is supported by the Roy Castle Lung Cancer Foundation. 
Access Research Report of Lung Cancer Diagnostics Market @ http://www.grandviewresearch.com/industry-analysis/lung-cancer-diagnostics-market

Further key findings from the study suggest:
·       The small cell lung cancer segment accounted for around 15% market share in 2015. This is an aggressive subtype of the lung malignancies, which has proven to be fatal within a short period of time if left undiagnosed.
·       Non-small cell lung cancer was identified as the largest segment in 2015 with revenue of over USD 1,300.0 million. This is majorly due to the availability of novel lung cancer diagnostics that facilitate the detection of large tumor growths.
·       The imaging tests segment was identified as the largest revenue generating segment in 2015 with a market share of around 50%. Major factors responsible for the large market share include the frequent use of various imaging techniques such as CT scan, X-ray, and MRI in the detection of lung malignancies coupled with the increased availability of the diagnostic tools.
·       The molecular testing segment is expected to grow at a profitable rate of around 10% over the forecast period. The introduction of novel molecular testing techniques coupled with the increasing number of investments to support the research and development efforts for the development of biomarker-based molecular testing in lung cancer detection is expected to foster the demand of this segment over the forecast period.
·       In 2015, North America accounted for the largest revenue share of over 30% majorly due to supportive government policies in the region coupled with the availability of technology-enabled lung cancer diagnostics
·       Asia Pacific region is expected to reach a revenue share of over 28% by 2024. Major factors responsible for the growth include the constantly improving healthcare infrastructure, the growing awareness of the disease symptoms, and a wide base of unmet clinical needs in the developing countries in the region.
·       Major players of this market include bioMérieux, Roche Diagnostics, Qiagen N.V., Illumina Inc., Thermo Fisher Scientific, Agilent Technologies, Janssen, AstraZeneca plc, and Sanofi S.A.
·       Novel product launches in the lung cancer diagnostics product portfolio is one of the major strategic initiatives adopted by the market players. For instance, Orion genomics is involved in the development of novel biomarkers for lung cancer diagnosis. Allegro Diagnostics is involved in the development and commercialization of pulmonary genomics-based lung cancer diagnostics. 
Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/clinical-diagnostics
 Grand View Research has segmented the global lung cancer diagnostics market on the basis of type, test, and region:
Global Lung Cancer Diagnostics Type Outlook (Revenue, USD Million, 2016 - 2024)
·         Small Cell Lung Cancer
·         Non-small Cell Lung Cancer
Global Lung Cancer Diagnostics Test Outlook (Revenue, USD Million, 2016 - 2024)
·         Imaging Test
·         Biopsy
·         Sputum Cytology
·         Molecular Test
·         Others
Lung Cancer Diagnostics Regional Outlook (Revenue, USD Million, 2016 - 2022)
·         North America
·         Europe
·         Asia Pacific
·         Latin America
·         MEA
Access Press Release of Lung Cancer Diagnostics Market@ https://www.grandviewresearch.com/press-release/global-lung-cancer-diagnostics-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Fetal Monitoring Equipment Market is Thriving $6.16 Billion Revenue by 2030: Grand View Research Inc.

  Fetal Monitoring Equipment Market Growth & Trends The global  fetal monitoring equipment market  size is anticipated to reach USD 6.16...